Table 4.
Analysis for factors influence the TMTA scores of T2DM patients
| β | 95% CL for β | P | |||
|---|---|---|---|---|---|
| lower | upper | ||||
| MoCA | Model 1 | -0.389 | -0.749 | -0.275 | 0.000* |
| Model 2 | -0.363 | -0.694 | -0.261 | 0.000* | |
| TMTA | Model 1 | 0.192 | 0.009 | 5.081 | 0.049* |
| Model 2 | 0.171 | 0.112 | 4.401 | 0.039* | |
Notes:
Model 1 indicated that IL-5 was a significant factor that influenced both MoCA score and TMTA score when age and gender were not adjusted for; Model 2 indicated that IL-5 was a significant factor that influenced both MoCA score and TMTA score after adjusting for age and gender
*P < 0.05
Abbreviations: TMTA, Trail Making Test-A; T2DM, type 2 diabetes mellitus; IL-5, interleukin-5